Selected research
Market Structure
Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 include Takeda, Jiangsu Hengrui Medicine Co Ltd, Jiangsu Nhwa Pharmaceutical Corp Ltd, Pfizer Inc, Primex Pharmaceuticals Oy and Paion AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size, projected growth trends, production technologies, key applications, and end-use industries.
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Company
Takeda
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Nhwa Pharmaceutical Corp Ltd
Pfizer Inc
Primex Pharmaceuticals Oy
Paion AG
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Type
EL-001
Midazolam Hydrochloride
LASSBio-786
LASSBio-785
Others
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Application
Insomnia
General Anesthetic Effect
Hypertension
Others
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 industry.
Chapter 3: Detailed analysis of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gamma-Aminobutyric Acid Receptor Subunit Gamma 2revenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- EL-001
- Midazolam Hydrochloride
- LASSBio-786
- LASSBio-785
- Others
Applications
- Insomnia
- General Anesthetic Effect
- Hypertension
- Others
Companies covered
- Takeda
- Jiangsu Hengrui Medicine Co Ltd
- Jiangsu Nhwa Pharmaceutical Corp Ltd
- Pfizer Inc
- Primex Pharmaceuticals Oy
- Paion AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 EL-001
- 1.2.3 Midazolam Hydrochloride
- 1.2.4 LASSBio-786
- 1.2.5 LASSBio-785
- 1.2.6 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Insomnia
- 1.3.3 General Anesthetic Effect
- 1.3.4 Hypertension
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Growth Trends by Region
- 1.5.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region (2021-2026)
- 1.5.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Dynamics
- 2.1 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Trends
- 2.2 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Drivers
- 2.3 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Opportunities and Challenges
- 2.4 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue by Company (2021-2026)
- 3.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Key Company Head office and Area Served
- 3.4 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company, Product Type & Application
- 3.5 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Players Market Share by Revenue in 2025
- 3.6.3 2025 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Tier 1, Tier 2, and Tier 3
4 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Type
- 4.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2021-2032)
- 4.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Share by Type (2021-2032)
5 Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market by Application
- 5.1 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2021-2032)
- 5.3 Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Takeda
- 6.1.1 Takeda Company Information
- 6.1.2 Takeda Business Overview
- 6.1.3 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Takeda Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.1.5 Takeda Recent Developments
- 6.2 Jiangsu Hengrui Medicine Co Ltd
- 6.2.1 Jiangsu Hengrui Medicine Co Ltd Company Information
- 6.2.2 Jiangsu Hengrui Medicine Co Ltd Business Overview
- 6.2.3 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Jiangsu Hengrui Medicine Co Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.2.5 Jiangsu Hengrui Medicine Co Ltd Recent Developments
- 6.3 Jiangsu Nhwa Pharmaceutical Corp Ltd
- 6.3.1 Jiangsu Nhwa Pharmaceutical Corp Ltd Company Information
- 6.3.2 Jiangsu Nhwa Pharmaceutical Corp Ltd Business Overview
- 6.3.3 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Jiangsu Nhwa Pharmaceutical Corp Ltd Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.3.5 Jiangsu Nhwa Pharmaceutical Corp Ltd Recent Developments
- 6.4 Pfizer Inc
- 6.4.1 Pfizer Inc Company Information
- 6.4.2 Pfizer Inc Business Overview
- 6.4.3 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Pfizer Inc Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.4.5 Pfizer Inc Recent Developments
- 6.5 Primex Pharmaceuticals Oy
- 6.5.1 Primex Pharmaceuticals Oy Company Information
- 6.5.2 Primex Pharmaceuticals Oy Business Overview
- 6.5.3 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Primex Pharmaceuticals Oy Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.5.5 Primex Pharmaceuticals Oy Recent Developments
- 6.6 Paion AG
- 6.6.1 Paion AG Company Information
- 6.6.2 Paion AG Business Overview
- 6.6.3 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Paion AG Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Product Portfolio
- 6.6.5 Paion AG Recent Developments
7 North America
- 7.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size (2021-2032)
- 7.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type
- 7.2.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2021-2026)
- 7.2.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2027-2032)
- 7.2.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Type (2021-2032)
- 7.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application
- 7.3.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2021-2026)
- 7.3.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2027-2032)
- 7.3.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Application (2021-2032)
- 7.4 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
- 7.4.1 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021-2026)
- 7.4.3 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2027-2032)
- 7.4.4 North America Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size (2021-2032)
- 8.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type
- 8.2.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2021-2026)
- 8.2.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2027-2032)
- 8.2.3 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Type (2021-2032)
- 8.3 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application
- 8.3.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2021-2026)
- 8.3.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2027-2032)
- 8.3.3 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Application (2021-2032)
- 8.4 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
- 8.4.1 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021-2026)
- 8.4.3 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2027-2032)
- 8.4.4 Europe Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size (2021-2032)
- 9.2 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type
- 9.2.1 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2021-2026)
- 9.2.2 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2027-2032)
- 9.2.3 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Type (2021-2032)
- 9.3 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application
- 9.3.1 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2021-2026)
- 9.3.2 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2027-2032)
- 9.3.3 China Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size (2021-2032)
- 10.2 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type
- 10.2.1 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2021-2026)
- 10.2.2 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2027-2032)
- 10.2.3 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Type (2021-2032)
- 10.3 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application
- 10.3.1 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2021-2026)
- 10.3.2 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2027-2032)
- 10.3.3 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Application (2021-2032)
- 10.4 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
- 10.4.1 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021-2026)
- 10.4.3 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2027-2032)
- 10.4.4 Asia Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type
- 11.2.1 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application
- 11.3.1 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country
- 11.4.1 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst